nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfinpyrazone—CYP2C9—brain cancer	0.498	1	CbGaD
Sulfinpyrazone—ABCC6—Etoposide—brain cancer	0.168	0.35	CbGbCtD
Sulfinpyrazone—ABCC3—Etoposide—brain cancer	0.0807	0.168	CbGbCtD
Sulfinpyrazone—ABCC1—Etoposide—brain cancer	0.0495	0.103	CbGbCtD
Sulfinpyrazone—ABCC2—Carboplatin—brain cancer	0.0437	0.091	CbGbCtD
Sulfinpyrazone—ABCC2—Etoposide—brain cancer	0.0367	0.0764	CbGbCtD
Sulfinpyrazone—CYP3A4—Temozolomide—brain cancer	0.0349	0.0727	CbGbCtD
Sulfinpyrazone—CYP3A4—Lomustine—brain cancer	0.0296	0.0618	CbGbCtD
Sulfinpyrazone—CYP2C8—Etoposide—brain cancer	0.0177	0.0368	CbGbCtD
Sulfinpyrazone—ABCB1—Etoposide—brain cancer	0.012	0.0249	CbGbCtD
Sulfinpyrazone—CYP3A4—Etoposide—brain cancer	0.00716	0.0149	CbGbCtD
Sulfinpyrazone—ABCC6—Podofilox—Etoposide—brain cancer	0.00334	1	CbGdCrCtD
Sulfinpyrazone—Phenylbutazone—CYP2C9—brain cancer	0.00096	0.377	CrCbGaD
Sulfinpyrazone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.000876	0.0533	CbGpPWpGaD
Sulfinpyrazone—Clotrimazole—CYP2C9—brain cancer	0.00086	0.338	CrCbGaD
Sulfinpyrazone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000787	0.0479	CbGpPWpGaD
Sulfinpyrazone—Cinnarizine—CYP2C9—brain cancer	0.000727	0.286	CrCbGaD
Sulfinpyrazone—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.000721	0.0439	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000717	0.0436	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00061	0.0371	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000607	0.037	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000578	0.0352	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Ectoderm Differentiation—TSC22D1—brain cancer	0.000537	0.0327	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000481	0.0293	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000458	0.0279	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000447	0.0272	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000378	0.023	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000364	0.0221	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000333	0.0203	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000307	0.0187	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000292	0.0178	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Irinotecan Pathway—APC—brain cancer	0.000247	0.015	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Irinotecan Pathway—APC—brain cancer	0.000244	0.0149	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Transmembrane transport of small molecules—S100A10—brain cancer	0.000231	0.0141	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000226	0.0138	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000216	0.0131	CbGpPWpGaD
Sulfinpyrazone—ABCC6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000206	0.0125	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000203	0.0124	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000195	0.0119	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000186	0.0113	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000183	0.0111	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000182	0.0111	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000157	0.00956	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000155	0.00944	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000153	0.00932	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00015	0.00916	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000139	0.00849	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000133	0.00808	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000127	0.00775	CbGpPWpGaD
Sulfinpyrazone—ABCC1—S1P1 pathway—VEGFA—brain cancer	0.000114	0.00697	CbGpPWpGaD
Sulfinpyrazone—SLC22A12—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000107	0.00649	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Ectoderm Differentiation—SHH—brain cancer	0.000102	0.00624	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Fluoropyrimidine Activity—TP53—brain cancer	9.63e-05	0.00586	CbGpPWpGaD
Sulfinpyrazone—ABCC6—Transmembrane transport of small molecules—TRPC6—brain cancer	9.5e-05	0.00578	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—S100A10—brain cancer	9.45e-05	0.00575	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Carbohydrate metabolism—ENO2—brain cancer	8.93e-05	0.00544	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	8.82e-05	0.00537	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	8.43e-05	0.00513	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	8.32e-05	0.00506	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Biological oxidations—CYP2C9—brain cancer	7.99e-05	0.00486	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—MPL—brain cancer	7.89e-05	0.0048	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	7.88e-05	0.0048	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	7.86e-05	0.00478	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—S100A10—brain cancer	7.57e-05	0.00461	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Irinotecan Pathway—APC—brain cancer	7.16e-05	0.00436	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Fluoropyrimidine Activity—TP53—brain cancer	7.1e-05	0.00432	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—S100A10—brain cancer	6.97e-05	0.00424	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	6.84e-05	0.00416	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—TRPC6—brain cancer	6.78e-05	0.00413	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Biological oxidations—CYP2C9—brain cancer	6.76e-05	0.00412	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Fluoropyrimidine Activity—TP53—brain cancer	6.67e-05	0.00406	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	6.67e-05	0.00406	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—S100A10—brain cancer	6.55e-05	0.00399	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—DTX2—brain cancer	6.48e-05	0.00395	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	6.35e-05	0.00387	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.07e-05	0.0037	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	5.52e-05	0.00336	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	5.5e-05	0.00335	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	5.46e-05	0.00332	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—BSG—brain cancer	5.33e-05	0.00324	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—VAV1—brain cancer	5.08e-05	0.00309	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—HES5—brain cancer	4.76e-05	0.0029	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.76e-05	0.0029	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.44e-05	0.0027	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Transmembrane transport of small molecules—TRPC6—brain cancer	4.36e-05	0.00266	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet degranulation—VEGFA—brain cancer	4.35e-05	0.00265	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	4.14e-05	0.00252	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—PDGFRA—brain cancer	3.76e-05	0.00229	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—DTX2—brain cancer	3.74e-05	0.00228	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—CYP2C9—brain cancer	3.67e-05	0.00223	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	3.63e-05	0.00221	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	3.58e-05	0.00218	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—TRPC6—brain cancer	3.49e-05	0.00213	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.48e-05	0.00212	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	3.22e-05	0.00196	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Transmembrane transport of small molecules—TRPC6—brain cancer	3.22e-05	0.00196	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—IDH1—brain cancer	3.2e-05	0.00195	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Ectoderm Differentiation—CTNNB1—brain cancer	3.19e-05	0.00194	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	3.13e-05	0.00191	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—BSG—brain cancer	3.12e-05	0.0019	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—HEY1—brain cancer	3.04e-05	0.00185	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Transmembrane transport of small molecules—TRPC6—brain cancer	3.02e-05	0.00184	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—DLL1—brain cancer	2.98e-05	0.00181	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	2.97e-05	0.00181	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—HES5—brain cancer	2.75e-05	0.00167	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—CYP2C9—brain cancer	2.7e-05	0.00165	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—IDH1—brain cancer	2.68e-05	0.00163	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—VAV1—brain cancer	2.62e-05	0.00159	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.6e-05	0.00158	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	2.6e-05	0.00158	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Ectoderm Differentiation—MYC—brain cancer	2.59e-05	0.00157	CbGpPWpGaD
Sulfinpyrazone—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.55e-05	0.00155	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—ENO2—brain cancer	2.53e-05	0.00154	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—SHH—brain cancer	2.53e-05	0.00154	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.52e-05	0.00153	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	2.51e-05	0.00153	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	2.35e-05	0.00143	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—BSG—brain cancer	2.3e-05	0.0014	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—IL2—brain cancer	2.27e-05	0.00138	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—ENO2—brain cancer	2.12e-05	0.00129	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—CYP2C9—brain cancer	2.12e-05	0.00129	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.06e-05	0.00125	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—IL2—brain cancer	2.05e-05	0.00125	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.02e-05	0.00123	CbGpPWpGaD
Sulfinpyrazone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.01e-05	0.00122	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	1.99e-05	0.00121	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—IDH1—brain cancer	1.98e-05	0.0012	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.93e-05	0.00117	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.9e-05	0.00116	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	1.85e-05	0.00113	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—IDH1—brain cancer	1.85e-05	0.00113	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—VAV1—brain cancer	1.83e-05	0.00111	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—BSG—brain cancer	1.8e-05	0.0011	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.77e-05	0.00107	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—HEY1—brain cancer	1.75e-05	0.00107	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.74e-05	0.00106	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—DLL1—brain cancer	1.72e-05	0.00105	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—PIK3CG—brain cancer	1.66e-05	0.00101	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.61e-05	0.00098	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—HES1—brain cancer	1.57e-05	0.000957	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—ENO2—brain cancer	1.56e-05	0.000951	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—IDH1—brain cancer	1.55e-05	0.000943	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.55e-05	0.000941	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.53e-05	0.000929	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—PDGFRA—brain cancer	1.5e-05	0.000911	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—ENO2—brain cancer	1.46e-05	0.00089	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—SHH—brain cancer	1.46e-05	0.00089	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.44e-05	0.000875	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—CYP2C9—brain cancer	1.37e-05	0.000832	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—IRS2—brain cancer	1.31e-05	0.0008	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.26e-05	0.000768	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—ENO2—brain cancer	1.22e-05	0.000745	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.2e-05	0.00073	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—IL2—brain cancer	1.17e-05	0.000712	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—BSG—brain cancer	1.16e-05	0.000707	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—APC—brain cancer	1.16e-05	0.000707	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—CYP2C9—brain cancer	1.16e-05	0.000704	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.12e-05	0.000679	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—VAV1—brain cancer	1.06e-05	0.000643	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—CYP2C9—brain cancer	1.01e-05	0.000613	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—IDH1—brain cancer	9.99e-06	0.000608	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—VEGFA—brain cancer	9.94e-06	0.000605	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	9.86e-06	0.0006	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—BSG—brain cancer	9.84e-06	0.000599	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	9.76e-06	0.000594	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Metabolism—PIK3CG—brain cancer	9.72e-06	0.000592	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—HES1—brain cancer	9.08e-06	0.000553	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—ERBB2—brain cancer	9.02e-06	0.000549	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—PDGFRA—brain cancer	8.65e-06	0.000527	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.59e-06	0.000523	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—BSG—brain cancer	8.57e-06	0.000522	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—IDH1—brain cancer	8.46e-06	0.000515	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—BSG—brain cancer	8.01e-06	0.000487	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.91e-06	0.000481	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—ENO2—brain cancer	7.9e-06	0.000481	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—CTNNB1—brain cancer	7.89e-06	0.00048	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.73e-06	0.000471	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—IRS2—brain cancer	7.59e-06	0.000462	CbGpPWpGaD
Sulfinpyrazone—ABCC4—Hemostasis—TP53—brain cancer	7.51e-06	0.000457	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—IDH1—brain cancer	7.37e-06	0.000449	CbGpPWpGaD
Sulfinpyrazone—ABCC3—Metabolism—PIK3CG—brain cancer	7.17e-06	0.000436	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.89e-06	0.000419	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—IDH1—brain cancer	6.88e-06	0.000419	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—STAT3—brain cancer	6.88e-06	0.000418	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—APC—brain cancer	6.71e-06	0.000408	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—ENO2—brain cancer	6.69e-06	0.000407	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.49e-06	0.000395	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—MYC—brain cancer	6.39e-06	0.000389	CbGpPWpGaD
Sulfinpyrazone—ABCC5—Disease—EGFR—brain cancer	6.25e-06	0.00038	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—CYP2C9—brain cancer	6.21e-06	0.000378	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—ENO2—brain cancer	5.83e-06	0.000355	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Metabolism—PIK3CG—brain cancer	5.62e-06	0.000342	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.61e-06	0.000341	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—ENO2—brain cancer	5.44e-06	0.000331	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—BSG—brain cancer	5.28e-06	0.000321	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—ERBB2—brain cancer	5.21e-06	0.000317	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—CTNNB1—brain cancer	4.56e-06	0.000277	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—IDH1—brain cancer	4.54e-06	0.000276	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—STAT3—brain cancer	3.97e-06	0.000242	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—MYC—brain cancer	3.69e-06	0.000225	CbGpPWpGaD
Sulfinpyrazone—CYP2B6—Metabolism—PIK3CG—brain cancer	3.62e-06	0.000221	CbGpPWpGaD
Sulfinpyrazone—ABCC1—Disease—EGFR—brain cancer	3.61e-06	0.00022	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—ENO2—brain cancer	3.59e-06	0.000218	CbGpPWpGaD
Sulfinpyrazone—CYP2C8—Metabolism—PIK3CG—brain cancer	3.07e-06	0.000187	CbGpPWpGaD
Sulfinpyrazone—ABCB1—Metabolism—PIK3CG—brain cancer	2.67e-06	0.000163	CbGpPWpGaD
Sulfinpyrazone—CYP2C9—Metabolism—PIK3CG—brain cancer	2.5e-06	0.000152	CbGpPWpGaD
Sulfinpyrazone—CYP3A4—Metabolism—PIK3CG—brain cancer	1.65e-06	0.0001	CbGpPWpGaD
